中文English
中文English
Emergency notice
Column:Company News Time:2021-06-08

In the global fight with SARS-CoV-2 pandemic, Xiamen Wiz Biotech responded quickly and fully mobilizing the company's R & D, production, registration and sales forces, successfully developed and sold a variety of SARS-CoV-2 rapid test kits. During the entire anti-epidemic process, we strictly comply with the laws and regulations in all aspects of production and sales. At present, our products have obtained EU CE, UK MHRA, the registration certificates of Indonesia, Bolivia, Brazil, Mexico, Ecuador, Turkey, and have obtained emergency authorization for home self-testing in Austria, Czech Republic and Germany. Products are sold to United Kingdom, Indonesia, Bolivia, Brazil, Mexico, Ecuador, Turkey, Italy, Germany, Spain, Austria, France, Czech Republic, Greece, Slovenia, Slovakia. We work hard to provide strong support for local epidemic prevention and control. However, our company heard that some distributers sold our products to the countries that are unauthorized and unregistered without the company’s consent, and have caused local FDA warnings. For this kind of behavior, our company We firmly oppose and press for all distributers to comply with relevant laws and regulations for sales. For such violations, the interests of our company have been seriously damaged and have a great negative impact on our company. We will reserve the right to be investigated by law.